Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy

BACKGROUND: Prostate specific antigen (PSA) is an important biomarker to monitor the response to the treatment, but has not been fully utilized as a whole sequence. We used a longitudinal biomarker PSA to discover a new prognostic pattern that predicts castration-resistant prostate cancer (CRPC) aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yejin, Park, Yong Hyun, Lee, Ji Youl, Choi, In Young, Yu, Hwanjo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959354/
https://www.ncbi.nlm.nih.gov/pubmed/27453983
http://dx.doi.org/10.1186/s12911-016-0297-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959354/
https://www.ncbi.nlm.nih.gov/pubmed/27453983
http://dx.doi.org/10.1186/s12911-016-0297-0

Ejemplares similares